Rep. Josh Gottheimer sold DexCom (DXCM)
Rep. Josh Gottheimer (D-NJ-5) · $1K–$15K · traded Aug 21, 2023
- Transaction
- Sold (partial)
- Amount
- $1K–$15K
- Owner
- Joint
- Traded
- Aug 21, 2023
- Disclosed
- Sep 16, 2023
- Days to disclose
- 26
- Asset type
- Stock
- As filed
- DexCom, Inc.
- Industry
- Medical - Devices · Healthcare
Other trades in this filing
All of Gottheimer's trades →- Sep 16, 2023$1K–$15K
$1K–$15K · Traded Aug 25, 2023 · disclosed Sep 16, 2023 · Joint
Got $1K from the company’s PAC - Sep 16, 2023$1K–$15K
$1K–$15K · Traded Aug 25, 2023 · disclosed Sep 16, 2023 · Joint
- Sep 16, 2023$1K–$15K
Sold (partial) Verizon Communications VZ
$1K–$15K · Traded Aug 24, 2023 · disclosed Sep 16, 2023 · Joint
Got $15K from the company’s PAC - Sep 16, 2023$1K–$15K
$1K–$15K · Traded Aug 24, 2023 · disclosed Sep 16, 2023 · Joint
Got $5K from the company’s PAC - Sep 16, 2023$1K–$15K
$1K–$15K · Traded Aug 24, 2023 · disclosed Sep 16, 2023 · Joint
Got $1K from the company’s PAC - Sep 16, 2023$1K–$15K
$1K–$15K · Traded Aug 22, 2023 · disclosed Sep 16, 2023 · Joint
- Sep 16, 2023$1K–$15K
$1K–$15K · Traded Aug 22, 2023 · disclosed Sep 16, 2023 · Joint
Got $3K from the company’s PAC - Sep 16, 2023$1K–$15K
$1K–$15K · Traded Aug 22, 2023 · disclosed Sep 16, 2023 · Joint
- Sep 16, 2023$1K–$15K
Bought ASSA ABLOY AB (publ) ASAZY
$1K–$15K · Traded Aug 22, 2023 · disclosed Sep 16, 2023 · Joint
- Sep 16, 2023$1K–$15K
$1K–$15K · Traded Aug 21, 2023 · disclosed Sep 16, 2023 · Joint
Got $5K from the company’s PAC - Sep 16, 2023$1K–$15K
Bought Regeneron Pharmaceuticals REGN
$1K–$15K · Traded Aug 21, 2023 · disclosed Sep 16, 2023 · Joint
- Sep 16, 2023$1K–$15K
$1K–$15K · Traded Aug 21, 2023 · disclosed Sep 16, 2023 · Joint
Got $4K from the company’s PAC - Sep 16, 2023$1K–$15K
Sold (partial) Freeport-McMoRan FCX
$1K–$15K · Traded Aug 21, 2023 · disclosed Sep 16, 2023 · Joint
- Sep 16, 2023$1K–$15K
Bought ASSA ABLOY AB (publ) ASAZY
$1K–$15K · Traded Aug 21, 2023 · disclosed Sep 16, 2023 · Joint
- Sep 16, 2023$1K–$15K
$1K–$15K · Traded Aug 21, 2023 · disclosed Sep 16, 2023 · Joint
- Sep 16, 2023$1K–$15K
Bought Haier Smart Home Co. HSHCY
$1K–$15K · Traded Aug 18, 2023 · disclosed Sep 16, 2023 · Joint
- Sep 16, 2023$1K–$15K
Bought Eli Lilly and Company LLY
$1K–$15K · Traded Aug 18, 2023 · disclosed Sep 16, 2023 · Joint
Got $10K from the company’s PAC - Sep 16, 2023$1K–$15K
Bought Dassault Systèmes SE DASTY
$1K–$15K · Traded Aug 18, 2023 · disclosed Sep 16, 2023 · Joint
- Sep 16, 2023$1K–$15K
Bought Chugai Pharmaceutical Co. CHGCY
$1K–$15K · Traded Aug 18, 2023 · disclosed Sep 16, 2023 · Joint
- Sep 16, 2023$1M–$5M
$1M–$5M · Traded Aug 15, 2023 · disclosed Sep 16, 2023 · Joint
Got $4K from the company’s PAC
Recent Congress trades in DXCM
- May 11, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Apr 13, 2026 · disclosed May 11, 2026 · Spouse
- May 10, 2026$100K–$250K
Sen. Tina Smith (D-MN)
$100K–$250K · Traded May 7, 2026 · disclosed May 10, 2026 · Spouse
- May 10, 2026$100K–$250K
Sen. Tina Smith (D-MN)
$100K–$250K · Traded Apr 29, 2026 · disclosed May 10, 2026 · Spouse
- Feb 15, 2026$1K–$15K
Sen. John Boozman (R-AR)
$1K–$15K · Traded Jan 26, 2026 · disclosed Feb 15, 2026 · Joint
- Feb 6, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Jan 29, 2026 · disclosed Feb 6, 2026 · Spouse
- Jun 22, 2025$15K–$50K
Rep. Jefferson Shreve (R-IN-6)
$15K–$50K · Traded May 12, 2025 · disclosed Jun 22, 2025
- Jun 22, 2025$15K–$50K
Rep. Jefferson Shreve (R-IN-6)
$15K–$50K · Traded May 8, 2025 · disclosed Jun 22, 2025
- Jun 9, 2025$1K–$15K
Rep. Robert P. Bresnahan, Jr. (R-PA-8)
$1K–$15K · Traded May 15, 2025 · disclosed Jun 9, 2025
Company context for DXCM
Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.
DXCM: third_quarter 2026 lobbying report
General representation. Legislative and regulatory issues related to policies and payments for continuous glucose monitoring
Public: Oct 20, 2026, 1:07 PM EDTOriginal source ↗DXCM: third_quarter 2026 lobbying report
Issues related to global supply chains Issues related to the Administration's Executive Orders CGM Coverage policy Issues related to sterilization of medical devices Issues related to medical device electronic labeling H.R.1539, Medical Device Electronic Labeling Act Issues related to artificial intelligence and other machine learning advances in healthcare Issues related to advances in diabetes technology Issues related to CY 2026 rulemaking CGM Coverage policies Issues related to breakthrough technology
Public: Oct 20, 2026, 11:00 AM EDTOriginal source ↗DXCM: third_quarter 2026 lobbying report
Issues related to coverage and reimbursement for continuous glucose monitors. Issues related to coverage and reimbursement for continuous glucose monitors.
Public: Oct 20, 2026, 10:03 AM EDTOriginal source ↗
From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.